RUMPÍK, David, Tatana RUMPIKOVA, Michal POHANKA, Pavel VENTRUBA and Silvie BELASKOVA. Gestational surrogacy in the Czech Republic. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2019, vol. 163, No 2, p. 155-160. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2018.040.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Gestational surrogacy in the Czech Republic
Authors RUMPÍK, David (203 Czech Republic, guarantor, belonging to the institution), Tatana RUMPIKOVA (203 Czech Republic), Michal POHANKA (203 Czech Republic, belonging to the institution), Pavel VENTRUBA (203 Czech Republic, belonging to the institution) and Silvie BELASKOVA (203 Czech Republic).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2019, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30214 Obstetrics and gynaecology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.000
RIV identification code RIV/00216224:14110/19:00112515
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2018.040
UT WoS 000477957000008
Keywords in English gestational surrogacy; surrogate mother; intended parents; pregnancy rate; live birth rate
Tags 14110411, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 17/1/2020 13:52.
Abstract
Background. Gestational surrogacy, is a treatment option for women with certain clearly defined medical problems, usually an absent uterus, to help them have their own genetic children. The aim of our study was to review, evaluate and share our experience and outcomes over the last 13 years of the largest surrogacy program in the Czech republic. Methods. A total of 75 intended mothers and 82 surrogate mothers participated in this study. A retrospective cohort study was performed. Anonymized data were collected on 130 cycles of gestational surrogate (2004-2017) directly from the Clinic database. Results. We performed 130 in vitro fertilization cycles with gestational surrogacy which involved 73 fresh embryo transfers and 57 frozen embryo transfers. We achieved 57 (43.9%) pregnancies and 42 (32.3%) live births. The rate of multiple pregnancies was only 2.3 %.The most common indication for using was an absent or damaged uterus (65%), followed by medical conditions precluding pregnancy (23%) and repeated in vitro fertilization cycles or pregnancy failure (12%). Conclusion. In the 14 years of our experience, we have shown that treatment of young women with specific indications for gestational surrogacy is beneficial, successful and relatively free of complications. However, it is imperative to follow the medical indications for this treatment and specialist recommendations.
PrintDisplayed: 25/4/2024 17:05